Connect with us

Health

Japan To Treat COVID-19 As Common Flu

COVID-19
Spread the love

Japan has said it will start considering COVID-19 as being equivalent to the seasonal common flu.

Advertisement

Japan’s Prime Minister, Fumio Kishida, announced on Friday that COVID-19 would be reclassified to disease category five from the current level two, which puts COVID-19 on same level with Tuberculosis and SARS.

The new reclassification to category five, which would take effect from Spring of 2023, and will see the virus in same category as the common flu and cold.

Advertisement

The shift means that wearing face masks will no longer be necessary in indoor public spaces and it also ends the need for infected people and close contacts to self-isolate.

“As we try to restore the lifestyles of a normal Japan, we would like to shift various measures step by step.

Advertisement

“In order to return to our ordinary daily life in Japan while pursuing measures to adapt to living with the coronavirus, we will study concrete measures to gradually move on to a next step,” Kishida was quoted as saying by Daily Mail UK.

Although, some Japanese experts have questioned the timing of the announcement, given that Covid cases were on the rise in recent times, with the current number of cases each day reportedly 338 per 100,000 people, a number that is up 40 per cent from the previous week.

Advertisement

In recent weeks, there had also been an uptick in deaths correlated with a rise in infections in the elderly. Japan recorded 500 fatalities last Saturday.

“It’s still too early to tell if the current wave of infections has peaked,” the Director-General of Japan’s National Institute of Infectious Diseases, Takaji Wakita, said at a panel session at the Ministry of Health, Labour and Welfare in Tokyo on January 17.

Advertisement

Advertisement
Continue Reading
Advertisement
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Health

Nigerian researchers hand over Covid-19 vaccine for pre-clinical trial

passengers, NCDC
Spread the love

By Francesca Iwambe, Abuja

Advertisement

Nigerian researchers engaged in the Tertiary Education Trust Fund-sponsored Vaccine Development Mega Research Project at Usman Danfodio University, Sokoto, have successfully handed over the Covid-19 DNA vaccine candidate for preclinical trials in Nigeria.

The academics, in a symbolic handover of the vaccine candidate in Sokoto for trial, said despite the numerous challenges faced during the procurement of some of the consumables, equipment and reagents from abroad, within 11 months of the receipt of the first tranche of TETFund grant, the vaccine was ready.

Advertisement

Speaking at the “Presentation of Milestone on the TETFund-sponsored Vaccine Development Mega Research Project,” Vice Chancellor of Usman Danfodio University, Sokoto, Prof Lawal Suleman Bilbis, said the handing over of a vaccine candidate for trials goes a long way to showcase the ability of indigenous scientists to solve the nation’s problems using home-grown resources and facilities.

Bilbis also said the “milestone portrays our expertise in the application of state-of-the art technologies to rapidly develop vaccine candidates against any emerging or re-emerging Infectious diseases in Nigeria.”

Advertisement

He assured that the nation is very close to reaping the benefits of the investment and confidence bestowed upon us, adding that they will converge in the next few months to celebrate the successful completion of this project.

“Let me at this juncture Inform the Executive Secretary that through the support of TETFUND, researchers in this University have been able to work on many other high-impact projects that are already yielding promising results.

Advertisement

“As I speak, we have successfully designed and constructed a recombinant DNA vaccine targeting all the lineages of Lassa virus circulating in Nigeria, using a TETFUND National Research Fund (NRF) grant. Additionally, TETFUND Covid-19 Special Intervention Research Grant has supported our study on the innovative approach to rapidly identify potential therapeutics for COVID-19.

“The study identified 7 orthodox medicines for repurposing and 2 herbal medicines with significant inhibitory activities against the virus that causes COVID-19. Indeed, there are many more TETFund-supported projects, too numerous to mention, which are helping our researchers to showcase their talents and skills, while at the same time, assisting to solve the nation’s problems. We remain extremely grateful to TETFUND for its support,” he said.

Advertisement

The Executive Secretary of TETFund, Arc Sonny Echono, on his part commended the efforts and output by Usman Danfodio University in terms of research and Development, adding that the University has succeeded in accessing over 35 NRF grants over the years, placing it among the best performing Institutions in accessing the National Research Fund, NRF.

Echono appealed to Nigerian researchers not to relent on the overarching goal of delivering a homemade Covid-19 vaccine.

Advertisement

The TETFund boss also disclosed that the mega research project is one out of four projects supported by the fund at a total sum of N1,250,000,000.

He said the aim of the research is to “strengthen collaborative research by promoting decentralized cooperation involving clusters of researchers from different institutions to consolidate problem-solving research and promote Innovation in Nigeria.”

Advertisement

According to him, TETFund has been making concerted efforts to identify more innovative ways of using government and donor funding in research programmes and projects for maximum developmental impact.

“This Project has shown that collaboration among stakeholders, each adding value from their area of specialization to address issues of national priority will achieve the desired goals towards national development and tackling of developmental challenges.

Advertisement

“It also indicates to us that we are moving in the right direction, as one of the mandates of the Fund’s R&D department is to promote multi- disciplinary research that will increase stakeholders’ participation in developmental matters,” he said.

Advertisement
Continue Reading

Health

Nigeria at very high risk of increased Lassa fever transmission –NCDC warns

Spread the love

By Francesca Iwambe, Abuja

Advertisement

The Nigeria Centre for Disease Control (NCDC) has warned that the country is at a very high risk of increased Lassa fever transmission.

In a statement issued on Monday, the agency stated that it has activated the national multi-sectoral emergency operations centre for Lassa fever (LF-EOC) at level 2 to coordinate and strengthen ongoing response activities in the country.

Advertisement

According to the NCDC, the operations centre was activated following a risk assessment carried out on January 20 by its experts and relevant stakeholders.

“The outcome of the risk assessment placed the country at a very high risk of increased Lassa fever transmission due to an unprecedented upward trend in the number of confirmed cases being reported compared to previous years, increased number of states reporting cases in comparison to previous years and increased risk of healthcare worker infections and deaths due to Lassa fever infection,” the statement reads.

Advertisement

“Infection and death among the healthcare workers accounted for 5 and 1 of the confirmed cases and deaths respectively, highlighting the need for an increased index of suspicion among healthcare workers.”

The NCDC said the purpose of emergency operations centre activation was to achieve a coordinated national response and reduce suffering and death due to the disease.

Advertisement

“Ahead of the projected rise of Lassa fever cases and as the country began to witness a rise in cases in the last week on November 2022, the NCDC prepositioned supplies for case management, infection prevention and control, laboratory diagnosis, etc. in all historical Lassa fever hotspots in the country.”

“This was complemented by correspondence sent to the Honourable Commissioners of Health, the Nigerian Governors’ Forum, State Ministries of Health, and respective professional bodies of healthcare workers to alert and sensitize them on the situation as well as to advocate for in-State activities to respond to Lassa fever.”

Advertisement

It could be recalled that as of January 22, Nigeria recorded 244 confirmed cases with 37 deaths from 16 states and the FCT.

Advertisement
Continue Reading

Health

Lassa fever cases rise as 37 persons killed in three weeks –NCDC

Akwa, fever, NCDC
Spread the love

By Francesca Iwambe, Abuja

Advertisement

The Nigeria Centre for Disease Control (NCDC) has said that at least 244 Lassa fever cases have been recorded in the country in 2023.

The agency’s latest Lassa fever report said 137 new cases were recorded in week three from January 16 to January 22.

Advertisement

The cases were reported from Ondo, Edo, Taraba, Benue, Nasarawa, Bauchi, Ebonyi, Plateau, Kogi, Anambra, Delta, FCT, Adamawa, and Enugu states.

The new figure shows a 77.9 percent increase from the cases recorded in week 2.

Advertisement

The agency also said 18 more people have died from the disease, bringing the number of deaths in 2023 to 37.

“In week 3, the number of new confirmed cases increased from 77 in week 2 2023 to 137 cases,” the report reads.

Advertisement

“Cumulatively from week 1 to week 3, 2023, 37 deaths have been reported with a case fatality rate (CFR) of 15.1% which is lower than the CFR for the same period in 2022 (18.8%).

 

Advertisement

“In total for 2023, 16 states have recorded at least one confirmed case across 50 Local Government Areas.

“Seventy-nine (79%) of all confirmed Lassa fever cases were reported from these three states (Ondo, Edo, and Bauchi) while 21% were reported from 13 states with confirmed Lassa fever cases. Of the 79% of confirmed cases, Ondo reported 37%, Edo 36%, and Bauchi 5%.

Advertisement

“The predominant age group affected is 21-30 years (Range: 1 to 79 years, Median Age: 30 years). The male-to-female ratio for confirmed cases is 1:0.9.

“The number of suspected cases increased compared to that reported for the same period in 2022.

Advertisement

“Two new Healthcare workers were affected in the reporting week 3.”

Advertisement
Continue Reading
Advertisement
Advertisement

Most Read Stories